Midland Daily News on MSN
CSFR installs seven public access naloxone harm reduction stations
The new stations installed by the Coalition in the past year complement nine other locations where naloxone and other harm ...
The FDA has approved axatilimab-csfr (Niktimvo) for treating adults and children with chronic graft-versus-host disease who have progressed on at least 2 prior treatments. The FDA approved ...
WALTHAM, Mass., Nov. 5, 2024 /PRNewswire/ -- Syndax Pharmaceuticals (Nasdaq:SNDX), today announced that multiple abstracts evaluating Niktimvo™ (axatilimab-csfr), an anti-CSF-1R antibody for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results